Locally Advanced Oral Squamous Cell Carcinomas: Auditing and Outcome Appraisal

Overview

Journal Indian J Otolaryngol Head Neck Surg

Publisher Springer

Date 2024 Mar 18

PMID 38495795

Authors

Rathindra Nath Bera

Richik Tripathi

Sapna Tandon

Mohd Adil

Sanober Sohail

Shashank

Avishek Chakraborty

Affiliations

Soon will be listed here.

Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s12070-023-04168-4.

Citing Articles

Hyperprogression of buccal squamous cell carcinoma accompanied by carotid sinus syndrome: A case report.

Quan W, Ma J, Zhao X, Li Y, Wu Y Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025; 49(9):1531-1537.

PMID: 39931784 PMC: 11814385. DOI: 10.11817/j.issn.1672-7347.2024.240217.

References

Gore S, Crombie A, Batstone M, Clark J . Concurrent chemoradiotherapy compared with surgery and adjuvant radiotherapy for oral cavity squamous cell carcinoma. Head Neck. 2014; 37(4):518-23. DOI: 10.1002/hed.23626. View

Bernier J, Cooper J, Pajak T, Van Glabbeke M, Bourhis J, Forastiere A . Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005; 27(10):843-50. DOI: 10.1002/hed.20279. View

Alzahrani R, Obaid A, Al-Hakami H, Alshehri A, Al-Assaf H, Adas R . Locally Advanced Oral Cavity Cancers: What Is The Optimal Care?. Cancer Control. 2020; 27(1):1073274820920727. PMC: 7218312. DOI: 10.1177/1073274820920727. View

Liao C, Ng S, Chang J, Wang H, Hsueh C, Lee L . T4b oral cavity cancer below the mandibular notch is resectable with a favorable outcome. Oral Oncol. 2006; 43(6):570-9. DOI: 10.1016/j.oraloncology.2006.06.008. View

Ghi M, Paccagnella A, Ferrari D, Foa P, Alterio D, Codeca C . Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial. Ann Oncol. 2017; 28(9):2206-2212. DOI: 10.1093/annonc/mdx299. View

Patil V, Noronha V, Joshi A, Muddu V, Gulia S, Bhosale B . Induction chemotherapy in technically unresectable locally advanced oral cavity cancers: does it make a difference?. Indian J Cancer. 2013; 50(1):1-8. DOI: 10.4103/0019-509X.112263. View

Yousem D, Hatabu H, Hurst R, Seigerman H, Montone K, Weinstein G . Carotid artery invasion by head and neck masses: prediction with MR imaging. Radiology. 1995; 195(3):715-20. DOI: 10.1148/radiology.195.3.7754000. View

Licitra L, Grandi C, Guzzo M, Mariani L, Lo Vullo S, Valvo F . Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol. 2003; 21(2):327-33. DOI: 10.1200/JCO.2003.06.146. View

Foster C, Melotek J, Brisson R, Seiwert T, Cohen E, Stenson K . Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience. Oral Oncol. 2018; 80:16-22. DOI: 10.1016/j.oraloncology.2018.03.008. View

10.

Hitt R, Grau J, Lopez-Pousa A, Berrocal A, Garcia-Giron C, Irigoyen A . A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer. Ann Oncol. 2013; 25(1):216-25. DOI: 10.1093/annonc/mdt461. View

11.

Adelstein D, Li Y, Adams G, Wagner Jr H, Kish J, Ensley J . An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2002; 21(1):92-8. DOI: 10.1200/JCO.2003.01.008. View

12.

Mummudi N, Agarwal J, Chatterjee S, Mallick I, Ghosh-Laskar S . Oral Cavity Cancer in the Indian Subcontinent - Challenges and Opportunities. Clin Oncol (R Coll Radiol). 2019; 31(8):520-528. DOI: 10.1016/j.clon.2019.05.013. View

13.

Patil V, Prabhash K, Noronha V, Joshi A, Muddu V, Dhumal S . Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers. Oral Oncol. 2014; 50(10):1000-4. DOI: 10.1016/j.oraloncology.2014.07.015. View

14.

Yousem D, Gad K, Tufano R . Resectability issues with head and neck cancer. AJNR Am J Neuroradiol. 2006; 27(10):2024-36. PMC: 7977212. View

15.

Zhong L, Zhang C, Ren G, Guo W, William Jr W, Sun J . Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol. 2012; 31(6):744-51. PMC: 5569675. DOI: 10.1200/JCO.2012.43.8820. View

16.

Eisenhauer E, Therasse P, Bogaerts J, Schwartz L, Sargent D, Ford R . New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2008; 45(2):228-47. DOI: 10.1016/j.ejca.2008.10.026. View

17.

Haddad R, ONeill A, Rabinowits G, Tishler R, Khuri F, Adkins D . Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol. 2013; 14(3):257-64. DOI: 10.1016/S1470-2045(13)70011-1. View

18.

Joshi A, Patil V, Noronha V, Juvekar S, Deshmukh A, Chatturvedi P . Is there a role of induction chemotherapy followed by resection in T4b oral cavity cancers?. Indian J Cancer. 2013; 50(4):349-55. DOI: 10.4103/0019-509X.123627. View

19.

Kumar A, Singh R, Santhosh M, Vijay S, Surendran N, Sahu G . Role of structures in the masticator space in selecting patients with resectable T4b oral cancer: findings from a survival analysis. Int J Oral Maxillofac Surg. 2020; 50(5):579-584. DOI: 10.1016/j.ijom.2020.07.026. View

20.

Lacas B, Bourhis J, Overgaard J, Zhang Q, Gregoire V, Nankivell M . Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. Lancet Oncol. 2017; 18(9):1221-1237. PMC: 5737765. DOI: 10.1016/S1470-2045(17)30458-8. View